Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stroke prevention: age alone does not rule out warfarin.

× No keyword cloud information.

14 in total

1. Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation.

Authors: David M Dorfman; Ellen M Goonan; M Kay Boutilier; Petr Jarolim; Milenko Tanasijevica; Samuel Z Goldhaber
Journal: Vasc Med Date: 2005-02 Impact factor: 3.239

2. Anticoagulation management: a new approach.

Authors: Mark Wurster; Trisha Doran
Journal: Dis Manag Date: 2006-08

3. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).

Authors: Amar Rash; Tom Downes; Robin Portner; Wilf W Yeo; Nicolette Morgan; Kevin S Channer
Journal: Age Ageing Date: 2006-12-15 Impact factor: 10.668

4. Bleeding risk with warfarin is high among elderly.

Authors:
Journal: J Fam Pract Date: 2007-09 Impact factor: 0.493

5. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.

Authors: Daniel M Witt; Melanie A Sadler; Roberta L Shanahan; Georgann Mazzoli; Donald J Tillman
Journal: Chest Date: 2005-05 Impact factor: 9.410

6. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors: Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal: J Am Coll Cardiol Date: 2006-08-15 Impact factor: 24.094

7. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors: Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal: Ann Intern Med Date: 2007-06-19 Impact factor: 25.391

8. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.

Authors: Francisco Pérez-Gómez; Eduardo Alegría; Jesus Berjón; Jose A Iriarte; Javier Zumalde; Antonio Salvador; Luis Mataix
Journal: J Am Coll Cardiol Date: 2004-10-19 Impact factor: 24.094

Review 9. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors: Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal: Chest Date: 2004-09 Impact factor: 9.410

10. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

Authors: Jonathan Mant; F D Richard Hobbs; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; Ellen Murray
Journal: Lancet Date: 2007-08-11 Impact factor: 79.321

1 in total

Review 1. Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.

Authors: Christopher J Boos; Michael Nam; A J Camm
Journal: Heart Fail Rev Date: 2013-06-25 Impact factor: 4.214

1 in total